egfr mutations in nsclc
Published 6 years ago • 798 plays • Length 2:26Download video MP4
Download video MP3
Similar videos
-
1:41
egfr mutations in patients with lung cancer
-
4:10
egfr mutations in advanced nsclc - targeted therapies in lung cancer 2023
-
30:32
2023 best of lung: targeted therapies in lung cancer
-
3:14
advancements of targeted therapy for egfr mutations in nsclc
-
1:13
identification of egfr mutations impact overall prognosis in lung cancers
-
1:29
dr. lynch on targeting egfr mutation subtypes in lung cancer
-
1:14
evaluating the role of egfr mutations in the treatment of advanced nsclc
-
5:13
case 2: frontline therapy in egfr-mutated lung cancer
-
3:09
case 2: osimertinib in egfr-mutated lung cancer
-
20:34
2021 west oncology | lung cancer | egfr mutation therapy resistance and adcs and trop2
-
58:24
time for even more precision in testing and treatment of egfr-mutated nsclc
-
3:30
osimertinib for uncommon egfr mutations in nsclc
-
4:02
treatment of egfr mutated nsclc - 2022 program: targeted therapies forum - english
-
4:06
afatinib in patients with uncommon egfr mutations
-
0:48
current role of immunotherapy in egfr-mutant lung cancer
-
1:33
the role of plasma as a potential alternative to egfr mutation analysis in nsclc
-
0:48
investigating osimertinib for brain activity in egfr-mutated lung cancer
-
1:56
what targeted therapies are used for people with the egfr mutation?
-
5:53
targeted therapy in non-small cell lung cancer